A detailed history of Morgan Stanley transactions in First Tr ETF Vi Nasdaq Pharmac stock. As of the latest transaction made, Morgan Stanley holds 5,942 shares of FTXH stock, worth $161,681. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,942
Previous 2 297000.0%
Holding current value
$161,681
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$26.75 - $29.66 $158,895 - $176,180
5,940 Added 297000.0%
5,942 $171,000
Q1 2024

Aug 16, 2024

BUY
$26.93 - $28.34 $26 - $28
1 Added 100.0%
2 $0
Q1 2024

May 15, 2024

BUY
$26.93 - $28.34 $26 - $28
1 Added 100.0%
2 $0
Q4 2023

Aug 16, 2024

SELL
$23.92 - $26.67 $23 - $26
-1 Reduced 50.0%
1 $0
Q4 2023

Feb 13, 2024

BUY
$23.92 - $26.67 $23 - $26
1 New
1 $0
Q1 2022

May 13, 2022

SELL
$24.61 - $26.95 $14,766 - $16,170
-600 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$25.33 - $27.38 $15,197 - $16,428
600 New
600 $16,000

Others Institutions Holding FTXH

About FIRST TR ETF VI NASDAQ PHARMAC


  • Ticker FTXH
  • Sector ETFs
  • Industry ETFs
More about FTXH
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.